Intravenous human immunoglobulin for the treatment of recurrent focal myositis

Daniela Santos-Faria; Joana Sousa-Neves; Joana Leite Silva; Joana Ramos Rodrigues; Soraia Azevedo; Sérgio Alcino; Carmo Afonso; Filipa Teixeira

Intravenous human immunoglobulin for the treatment of recurrent focal myositis

Acta Reumatol Port. 2019 Jan-Mar;44(1):88-89.

Authors

Daniela Santos-Faria¹, Joana Sousa-Neves¹, Joana Leite Silva¹, Joana Ramos Rodrigues¹, Soraia Azevedo¹, Sérgio Alcino¹, Carmo Afonso¹, Filipa Teixeira¹

Affiliation

¹ Hospital Conde de Bertiandos - Unidade Local de Saúde do Alto Minho, Ponte de Lima, Portugal.

PMID: 31249282

Abstract

We present a case of recurrent focal myositis treated with intravenous human immunoglobulin, after ineffectiveness of analgesics, non-steroidal anti-inflammatory drugs, corticosteroids and immunosuppressive therapies. There was a prompt clinical and laboratorial improvement. To the best of our knowledge, this is the first case reporting the administration of this treatment in recurrent focal myositis.

Publication types

Case Reports
Letter

MeSH terms

Adult
Azathioprine / therapeutic use
Female
Glucocorticoids / therapeutic use
Humans
Immunoglobulins, Intravenous / therapeutic use*
Immunologic Factors / therapeutic use*
Methotrexate / therapeutic use
Myositis / drug therapy
Myositis / therapy*
Prednisolone / therapeutic use
Recurrence

Substances

Glucocorticoids
Immunoglobulins, Intravenous
Immunologic Factors
Prednisolone
Azathioprine
Methotrexate